Skip to main content
Translational Cancer Research logoLink to Translational Cancer Research
. 2024 Feb 28;13(2):1219–1220. doi: 10.21037/tcr-2023-08

Erratum to The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level

Editorial Office1
PMCID: PMC10928641  PMID: 38482407

In the August 2018 issue of Translational Cancer Research, the article “The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level” edited by Zhang et al. (1), was published with some errors in Figure 2 due to the misuse of the Figure 2B3. Figure 2 should be corrected as below and the figure legend remains intact.

Figure 2.

Figure 2

Infiltration of TAMs (F4/80+) and M2 macrophages (CD206+) in tumour tissues on days 7 and 14 after engraftment. (A,C) Infiltration of M2 macrophages in tumour tissues on days 7 and 14 after engraftment; (B,D) infiltration of TAMs macrophages in tumour tissues on days 7 and 14 after engraftment. *, P<0.05. TAM, tumour associated macrophage.

The authors apologize for this error, and state that this does not affect the scientific conclusions of the article.

Click here to view the updated version of the article.

References

  • 1.Zhang L, Yang B, Li X, et al. The targeting of endoglin on vascular endothelial cells affects the infiltration of M2 macrophages into the breast cancer microenvironment by modulating the interleukin-6 (IL-6) level. Transl Cancer Res 2018;7:912-21. 10.21037/tcr.2018.06.17 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Translational Cancer Research are provided here courtesy of AME Publications

RESOURCES